VANGUARD GROUP INC 13D and 13G filings for Corbus Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-29 11:26 am Sale | 2025-06-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | VANGUARD GROUP INC | 599,495 4.890% | -46,155 (-7.15%) | Filing |
| 2024-11-12 2:34 pm Unchanged | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | VANGUARD GROUP INC | 645,650 5.360% | 0 (Unchanged) | Filing |
| 2024-11-04 11:28 am Purchase | 2024-09-30 | 13G | CORBUS PHARMACEUTICALS HOLDING CRBP | VANGUARD GROUP INC | 645,650 5.360% | 645,650 (New Position) | Filing |